3-(1H-indol-2-yl)pyrazin-2-amine | 581081-38-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 3-(1H-indol-2-yl)pyrazin-2-amine
• CAS: 581081-38-1
• 化学式: C₁₂H₁₀N₄
• 分子量: 210.238
• InChiKey: FUJKGZVXJCWRRN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  16
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  67.6
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  2,2,2-trifluoro-N-[3-(1H-indol-2-yl)pyrazin-2-yl]acetamide 在 水 、 potassium carbonate 作用下， 以 甲醇 为溶剂， 反应 12.0h， 以83%的产率得到3-(1H-indol-2-yl)pyrazin-2-amine
  参考文献：
  名称：

  室温下官能化苯胺和氨基取代的吡啶和吡嗪的邻位和间位放大

  摘要：

  一种实用的 邻位，间位，（或甚至邻位，邻位'）的苯胺，氨基吡啶，并在室温下aminopyrazines的trifluoroacetamides的镁化用TMPMgCl⋅LiCl或TMP进行2 Mg⋅2的LiCl。这些放大倍数与几种羰基官能度相容，并允许以令人满意的产率获得多取代的苯胺。

  DOI：

  10.1002/anie.201205465

文献信息

• Heteroaryl compounds useful as inhibitors of GSK-3
  申请人：——

  公开号：US20040034037A1

  公开（公告）日：2004-02-19

  The present invention relates to compounds of formula I useful as inhibitors of GSK-3 and Lck protein kinases. The present invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of utilizing those compositions in the treatment and prevention of various disorders, such as diabetes, Alzheimer's disease, and transplant rejection.

  本发明涉及式I的化合物，其可用作GSK-3和Lck蛋白激酶的抑制剂。本发明还提供了包含本发明化合物的药学上可接受的组合物，并提供了利用这些组合物在治疗和预防各种疾病，如糖尿病、阿尔茨海默病和移植排斥等方面的方法。
• HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF GSK-3
  申请人：Harbeson L. Scott

  公开号：US20070270420A1

  公开（公告）日：2007-11-22

  The present invention relates to compounds of formula I useful as inhibitors of GSK-3 and Lck protein kinases. The present invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of utilizing those compositions in the treatment and prevention of various disorders, such as diabetes, Alzheimer's disease, and transplant rejection.

  本发明涉及一种公式I的化合物，其可用作GSK-3和Lck蛋白激酶的抑制剂。本发明还提供了包含该发明化合物的药学上可接受的组合物，并提供了使用这些组合物治疗和预防各种疾病的方法，例如糖尿病、阿尔茨海默病和移植排斥反应。
• [EN] HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF GSK-3<br/>[FR] COMPOSES HETEROARYLES UTILES EN TANT QU'INHIBITEURS DE GSK-3
  申请人：VERTEX PHARMA

  公开号：WO2003066629A2

  公开（公告）日：2003-08-14

  The present invention relates to compounds of formula I wherein: Ring A is an optionally substituted 5-7 membered, partially unsaturated or fully unsaturated ring having 0-3 heteroatoms independently selected from nitrogen, oxygen or sulfur, and wherein Ring A is optionally fused to an optionally substituted saturated, partially unsaturated or fully unsaturated 5-8 member ring having 0-3 heteroatoms independently selected from nitrogen, oxygen or sulfur; Ring B is an optionally substituted 5-6 membered ring having 0 to 4 heteroatoms, independently selected from nitrogen, oxygen, or sulfur, wherein said ring has a first substituent, -N(R1)2, in the position adjacent to the point of attachment, and is optionally substituted by up to two additional substituents. Compoounds of formula I are useful as inhibitors of GSK-3 and Lck protein kinases. The present invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of utilizing those compositions in the treatment and prevention of various disorders, such as diabetes, Alzheimer’s disease, and transplant rejection.